U.S. FDA Designates Mallinckrodt's StrataGraft® as Regenerative Medicine Advanced Therapy
Go back to U.S. FDA Designates Mallinckrodt's StrataGraft® as Regenerative Medicine Advanced Therapy| Medtronic Inc. (NYSE: MDT) | Delayed: 94.17 +1.07 (1.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $93.10 | 52 Week High | $89.27 | |||
| Open | $92.76 | 52 Week Low | $71.03 | |||
| Day High | $94.74 | P/E | 26.75 | |||
| Day Low | $92.31 | EPS | $3.52 | |||
| Volume | 9,013,443 | |||||
| MALLINCKRODT PUBLIC LIMITED COMPANY (NYSE: MNK) | Delayed: 0.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.34 | 52 Week High | $85.83 | |||
| Open | $30.62 | 52 Week Low | $50.90 | |||
| Day High | $0.34 | P/E | 0.34 | |||
| Day Low | $0.34 | EPS | $1.00 | |||
| Volume | 84 | |||||
